Could a watchful software save ICU patients from organ failure?

NCT ID NCT07119411

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a special alert system called ICU Beacon can help doctors in intensive care units detect early signs of organ failure. The study includes about 1,962 adult ICU patients and compares units using the software plus standard care to those using standard care alone. The goal is to see if the software reduces deaths and limits organ damage during the first 28 days in the ICU.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ICU Beacon software (clinician awareness system)
What this could lead to
If it works, this software could help ICU teams detect early signs of organ failure sooner, potentially saving lives and reducing severe complications.
What could go wrong
This is a single-center trial, and results may not apply to all ICUs. The software is a decision-support tool, not a treatment, so its impact depends on how doctors use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRCULATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inselspital - Universitätsspital Bern

    RECRUITING

    Bern, 3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.